Érythropoïétine et insuffisance rénale : jusqu’où ne pas aller ?

Jauréguy, 2006, Facteurs de résistance à l’action des agents stimulant l’érythropoïèse, Nephrol Ther, 2 suppl 4, S274 Rossert, 2006, Diagnostic et traitement des érythroblastopénies induites par les agents stimulant l’érythropoïèse, Nephrol Ther, 2 suppl 4, S283 Locatelli, 2002, Once-weekly compared with three-times weekly subcutaneous epoetin bêta: results from a randomized, multicenter therapeutic-equivalence study, Am J Kidney Dis, 40, 119, 10.1053/ajkd.2002.33920 KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47 suppl 3, S33–S53. Locatelli, 2004, Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Section II. Targets for anaemia treatment, Nephrol Dial Transplant, 19 suppl 2, 6 AFSSAPS, 2005, Traitement de l’anémie au cours de l’insuffisance rénale chronique de l’adulte, recommandations de l’AFSSAPS, Nephrol Ther, 1 suppl 1, S1 Mercadal, 2006, Quelle est la valeur optimale de l’hémoglobinémie du patient dialysé ?, Nephrol Ther, 2 suppl 4, S239 Thamer, 2007, Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis, JAMA, 297, 1667, 10.1001/jama.297.15.1667 Jacobs, 2005, Results of the European Survey on Anaemia Management (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years, Nephrol Dial Transplant, 20 suppl 3, 3, 10.1093/ndt/gfh1074 Singh, 2006, Correction of anemia with epoetin alfa in chronic kidney disease, N Engl J Med, 355, 2085, 10.1056/NEJMoa065485 Drüeke, 2006, Normalization of hemoglobin level in patients with chronic kidney disease and anemia, N Engl J Med, 355, 2071, 10.1056/NEJMoa062276 Rossert, 2006, Effect of early correction of anemia on the progression of CKD, Am J Kidney Dis, 47, 738, 10.1053/j.ajkd.2006.02.170 Besarab, 1998, The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin, N Engl J Med, 339, 584, 10.1056/NEJM199808273390903 Parfrey, 2005, Double-blindcompararison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease, J Am Soc Nephrol, 16, 2180, 10.1681/ASN.2004121039 Strippoli, 2004, Hemoglobin targets for the anemia of chronic kidney diseases: a meta-analysis of randomized, controlled trials, J Am Soc Nephrol, 15, 3154, 10.1097/01.ASN.0000145436.09176.A7 Strippoli, 2006, Haemoglobin and haematocrit targets for the anaemia of chronic kidney diseases, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD003967.pub2 Phrommintikul, 2007, Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis, Lancet, 369, 381, 10.1016/S0140-6736(07)60194-9 Strippoli, 2007, Haemoglobin targets: we were wrong, time to move on, Lancet, 369, 346, 10.1016/S0140-6736(07)60165-2 Tonks, 2007, Too much of a good thing, BMJ, 334, 978, 10.1136/bmj.39198.510347.AD Remuzzi, 2006, Correction of anemia-payoffs and problems, N Engl J Med, 355, 2144, 10.1056/NEJMe068233 Steinbrook, 2006, Haemoglobin concentrations in chronic kidney disease, Lancet, 368, 2193, 10.1016/S0140-6736(06)69707-9 Coyne, 2007, Use of epoetin in chronic renal failure, JAMA, 297, 1713, 10.1001/jama.297.15.1713 Steinbrook, 2007, Guidance for guidelines, N Engl J Med, 356, 331, 10.1056/NEJMp068282 Macdougall, 2006, Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia, Lancet, 368, 947, 10.1016/S0140-6736(06)69120-4 Provenzano, 2007, The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study, Clin Nephrol, 67, 306 Levin, 2007, Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA), Lancet, 370, 1415, 10.1016/S0140-6736(07)61599-2